Anthony Iacovone

Anthony Iacovone is the Co-founder and CEO of BioSymetrics, a phenomics-driven drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and advance precision medicines. Prior to their current role, Iacovone served as the Owner of the New Britain Bees Professional Baseball Club from March 2017 to April 2021.

Iacovone has also held positions as the Founder and Chief Innovation Officer at Augme Mobile, Global Account Manager at Global Crossing, and Business Development at MCI. In their role at Augme Mobile, Iacovone was responsible for developing the company's flagship product, which was acquired by AmerisourceBergen in 2011.

A native of New York, Iacovone received a Bachelor's degree in Economics from the University of Rochester.

Anthony Iacovone has a degree from Concordia College.

Gabriel Musso - Chief Scientific Officer, Victoria Catterson - VP, Research, and Mikalai Malinouski - Business Development Director report to Anthony Iacovone.